Cyclo Therapeutics Inc
NASDAQ:CYTH

Watchlist Manager
Cyclo Therapeutics Inc Logo
Cyclo Therapeutics Inc
NASDAQ:CYTH
Watchlist
Price: 99 USD 12.08% Market Closed
Market Cap: 2.1B USD

Operating Margin
Cyclo Therapeutics Inc

-2 834.1%
Current
-1 499%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-2 834.1%
=
Operating Profit
-24.7m
/
Revenue
870.7k

Operating Margin Across Competitors

No Stocks Found

Cyclo Therapeutics Inc
Glance View

Market Cap
2.1B USD
Industry
Biotechnology

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. The company is headquartered in Gainesville Florida, Florida and currently employs 9 full-time employees. The company went IPO on 2004-02-27. The firm's lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) is for the treatment of Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. The company is also focusing on the use of cyclodextrins in the treatment of Alzheimer's disease. The firm's product lines include Trappsol and Aquaplex. The company sells its chemical products directly to customers in the pharmaceutical, diagnostics, and industrial chemical industries, and to chemical supply distributors. The firm also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

CYTH Intrinsic Value
709.64 USD
Undervaluation 86%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-2 834.1%
=
Operating Profit
-24.7m
/
Revenue
870.7k
What is the Operating Margin of Cyclo Therapeutics Inc?

Based on Cyclo Therapeutics Inc's most recent financial statements, the company has Operating Margin of -2 834.1%.

Back to Top